Global Rice Protein Based Infant Formula Market - Industry Trends and Forecast to 2026
Short Description
By Type (Formulated, Unformulated), Product Type (Standard Formula, Toddler Formula, Follow-On Formula, Special Formula), Form (Non-GMO, GMO), Infant Age (6-12 Months, 0-6 Months, 1-3 Years), Distribution Channel (Store-Based Retailer, Non-Store Retailer), Geography (Asia-Pacific, Europe, North America, South America, Middle East & Africa)
Market Definition:
Infant formulae are the specialized products which are developed for the proper dietary management of the infants and babies in the age group of 0-3 years. Rice protein based infant formula is specially used by the infants who are allergic to cow’s milk or soy. The formulations of the approved infant formula are not altered by the regulatory agencies without the prior approval for processing, modification and/or addition of ingredients.
Rice protein is referred to as a low quality protein as compared to the cow’s milk protein. The rice protein based infant formulas are lactose free and are not recommended for babies as the best choice with lactose intolerance. It acts as an alternative to the hydrolysed cow’s milk or the amino acid formulas and is also more palatable.
Market Segmentation:
Global rice protein based infant formula market is segmented into five notable segments which are type, product type, form, infant age and distribution channel.
• On the basis of type, the market is segmented into unformulated and formulated
• On the basis of product type, the market is segmented standard formula, toddler formula, follow-on formula and special formula
• On the basis of form, the market is segmented into Non-GMO and GMO
• On the basis of infant age, the market is segmented into 0-6 months, 6-12 months and 1-3 years
• On the basis of distribution channel, the market is segmented into store-based retailer and non-store retailer
Market Players
The key players of global rice protein based infant formula market are:
• Nucitec SA de CV
• La Mandorle
• Laboratorios Ordesa
• Kate Farms
• Bayer AG
• Lactalis International
• BIOLAB PHARMA
• Novalac
The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Global Rice Protein Based Infant Formula Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Global Rice Protein Based Infant Formula Market: Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Primary Interviews With Key Opinion Leaders
- 2.7 Dbmr Market Position Grid
- 2.8 Dbmr Vendor Share Analysis
- 2.9 Multivariate Modeling
- 2.10 Products Lifeline Curve
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Market Overview
- 3.1 Drivers
- 3.1.1 Rising Population Of Working Mothers
- 3.1.2 Growing Infant Population
- 3.1.3 Increasing Cases Of Breast Cancer
- 3.1.4 Rice Protein Based Infant Formula Is Widely Accepted As Non-allergic Product
- 3.2 Restraint
- 3.2.1 Stringent Regulation
- 3.3 Opportunities
- 3.3.1 Growing Economies And Disposable Income In Emerging Regions
- 3.3.2 Increasing Awareness Regarding Importance Of Nutrition For Infants
- 3.4 Challenges
- 3.4.1 High Content Of Toxic Chemicals In Rice Protein Based Infant Formula
- 3.4.2 Improper Packaging Of Baby Food
- 4 Executive Summary
- 5 Premium Insights
- 6 Global Rice Protein Based Infant Formula Market, By Product Type
- 6.1 Overview
- 6.2 Follow-on Formula
- 6.3 Toddler Formula
- 6.4 Standard Formula
- 6.5 Special Formula
- 7 Global Rice Protein Based Infant Formula Market, By Type
- 7.1 Overview
- 7.2 Unformulated
- 7.3 Formulated
- 7.3.1 Vegetables
- 7.3.2 Fruits
- 7.3.3 Cereal
- 8 Global Rice Protein Based Infant Formula Market, By Form
- 8.1 Overview
- 8.2 Non-gmo
- 8.3 Gmo
- 9 Global Rice Protein Based Infant Formula Market, By Infant Age
- 9.1 Overview
- 9.2 6-12 Months
- 9.3 1-3 Years
- 9.4 0-6 Months
- 10 Global Rice Protein Based Infant Formula Market, By Distribution Channel
- 10.1 Overview
- 10.2 Store-based Retailer
- 10.2.1 Convenience Stores
- 10.2.2 Supermarkets/Hypermarkets
- 10.2.3 Specialty Stores
- 10.2.4 Grocery Stores
- 10.2.5 Wholesalers
- 10.3 Non-store Retailer
- 10.3.1 Online
- 10.3.2 Vending
- 11 Global Rice Protein Based Infant Formula Market, By Geography
- 11.1 Overview
- 11.2 North America
- 11.2.1 U.S.
- 11.2.2 Canada
- 11.2.3 Mexico
- 11.3 Europe
- 11.3.1 Germany
- 11.3.2 France
- 11.3.3 U.K.
- 11.3.4 Italy
- 11.3.5 Spain
- 11.3.6 Netherlands
- 11.3.7 Poland
- 11.3.8 Sweden
- 11.3.9 Switzerland
- 11.3.10 Belgium
- 11.3.11 Denmark
- 11.3.12 Russia
- 11.3.13 Turkey
- 11.3.14 Rest Of Europe
- 11.4 Asia-pacific
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 South Korea
- 11.4.5 Australia
- 11.4.6 Singapore
- 11.4.7 Thailand
- 11.4.8 Indonesia
- 11.4.9 Malaysia
- 11.4.10 New Zealand
- 11.4.11 Philippines
- 11.4.12 Vietnam
- 11.4.13 Rest Of Asia-pacific
- 11.5 South America
- 11.5.1 Brazil
- 11.5.2 Argentina
- 11.5.3 Rest Of South America
- 11.6 Middle East & Africa
- 11.6.1 South Africa
- 11.6.2 Saudi Arabia
- 11.6.3 Uae
- 11.6.4 Kuwait
- 11.6.5 Oman
- 11.6.6 Qatar
- 11.6.7 Rest Of Middle East & Africa
- 12 Swot & Dbmr Analysis
- 12.1 Swot Analysis
- 12.2 Data Bridge Market Research Analysis
- 13 Global Rice Protein Based Infant Formula Market, Company Landscape
- 13.1 Company Share Analysis: Global
- 13.2 Company Share Analysis: North America
- 13.3 Company Share Analysis: Europe
- 13.4 Company Share Analysis: Asia-pacific
- 13.5 Company Share Analysis: Middle East & Africa
- 14 Company Profile
- 14.1 Lactalis International
- 14.1.1 Company Snapshot
- 14.1.2 Company Share Analysis
- 14.1.3 Product Portfolio
- 14.1.4 Recent Developments
- 14.2 Novalac
- 14.2.1 Company Snapshot
- 14.2.2 Company Share Analysis
- 14.2.3 Product Portfolio
- 14.2.4 Recent Development
- 14.3 Bayer Ag
- 14.3.1 Company Snapshot
- 14.3.2 Revenue Analysis
- 14.3.3 Company Share Analysis
- 14.3.4 Product Portfolio
- 14.3.5 Recent Development
- 14.4 Laboratorios Ordesa
- 14.4.1 Company Snapshot
- 14.4.2 Company Share Analysis
- 14.4.3 Product Portfolio
- 14.4.4 Recent Development
- 14.5 Biolab Pharma
- 14.5.1 Company Snapshot
- 14.5.2 Product Portfolio
- 14.5.3 Recent Development
- 14.6 Kate Farms
- 14.6.1 Company Snapshot
- 14.6.2 Product Portfolio
- 14.6.3 Recent Development
- 14.7 La Mandorle
- 14.7.1 Company Snapshot
- 14.7.2 Product Portfolio
- 14.7.3 Recent Development
- 14.8 Nucitec Sa De Cv
- 14.8.1 Company Snapshot
- 14.8.2 Product Portfolio
- 14.8.3 Recent Development
- 15 Questionnaire
- 16 Conclusion
- 17 Related Reports